• Adoport 0.5 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	0,511 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Sandoz Farmaceutica S.A.

• Adoport 1 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	1,022 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Sandoz Farmaceutica S.A.

• Adoport 2 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	2,044 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Sandoz Farmaceutica S.A.

• Adoport 5 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	5,11 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Sandoz Farmaceutica S.A.

• Cellmune 1 mg/g ointment

  Form: ointment

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	1,022 mg

  ATC: D11A D11AH D11AH01

  Manufacturer: Industrial Farmaceutica Cantabria S.A.

• Conferoport 0.5 mg prolonged-release hard capsules EFG

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	0.511 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Sandoz Farmaceutica S.A.

• Conferoport 1 mg prolonged-release hard capsules EFG

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	1.022 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Sandoz Farmaceutica S.A.

• Conferoport 2 mg prolonged-release hard capsules

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	2.045 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Sandoz Farmaceutica S.A.

• Conferoport 3 mg prolonged-release hard capsules EFG

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	3.067 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Sandoz Farmaceutica S.A.

• Conferoport 5 mg prolonged-release hard capsules EFG

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	5.112 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Sandoz Farmaceutica S.A.

• Envarsus 0.75 mg prolonged-release tablets

  Form: tablets, modified release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	0,765 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Chiesi Farmaceutici S.P.A.

• Envarsus 1 mg prolonged-release tablets

  Form: tablets, modified release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	1,02 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Chiesi Farmaceutici S.P.A.

• Envarsus 1 mg prolonged-release tablets

  Form: tablets, modified release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	1,02 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Chiesi Farmaceutici S.P.A.

• Envarsus 4 mg prolonged-release tablets

  Form: tablets, modified release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	4,08 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Chiesi Farmaceutici S.P.A.

• Modigraf 0.2 mg granules for oral suspension

  Form: suspension, oral for preparation from granules

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	0,2 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Astellas Pharma Europe B.V.

• Modigraf 1 mg granules for oral suspension

  Form: suspension, oral for preparation from granules

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	1 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Astellas Pharma Europe B.V.

• Protopic 0.03% ointment

  Form: ointment

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	0,3 mg

  ATC: D11A D11AH D11AH01

  Manufacturer: Leo Pharma A/S

• Protopic 0.03% ointment

  Form: ointment

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	0,3 mg

  ATC: D11A D11AH D11AH01

  Manufacturer: Leo Pharma A/S

• Protopic 0.1% ointment

  Form: ointment

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	1 mg

  ATC: D11A D11AH D11AH01

  Manufacturer: Leo Pharma A/S

• Protopic 0.1% ointment

  Form: ointment

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	1 mg

  ATC: D11A D11AH D11AH01

  Manufacturer: Leo Pharma A/S

• Tacforius 0.5 mg prolonged-release hard capsules EFG

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	0,5112 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Teva B.V.

• Tacforius 1 mg prolonged-release hard capsules EFG

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	1,0224 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Teva B.V.

• Tacforius 3 mg prolonged-release hard capsules EFG

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	3,0672 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Teva B.V.

• Tacforius 5 mg prolonged-release hard capsules EFG

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	5,112 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Teva B.V.

• Tacgalen 1 mg/ml cutaneous emulsion

  Form: emulsion, cutaneous

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	1,022 mg/ml

  ATC: D11A D11AH D11AH01

  Manufacturer: Galenicum Derma S.L.U.

• Tacrolimus Stadafarma 0.5 mg prolonged-release hard capsules EFG

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	0,511 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Laboratorio Stada S.L.

• Tacrolimus Stadafarma 1 mg prolonged-release hard capsules EFG

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	1,022 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Laboratorio Stada S.L.

• Tacrolimus Stadafarma 3 mg prolonged-release hard capsules EFG

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	3,0659 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Laboratorio Stada S.L.

• Tacrolimus Stadafarma 5 mg prolonged-release hard capsules EFG

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	5,1097 mg

  ATC: L04A L04AD L04AD02

  Manufacturer: Laboratorio Stada S.L.